Reporting Manager
Atlas Venture Associates XII, L.P.
Symbol
JBIO
Disclosed Ownership
51,406 shares
Ownership
0.2%
Form type
SCHEDULE 13D/A
Filing time
30 Apr 2025, 16:29:11 UTC
Date of event
28 Apr 2025

Quoteable Key Fact

"Atlas Venture Fund XII, L.P. disclosed 0.2% ownership in JADE BIOSCIENCES, INC. Common Stock (JBIO) on 28 Apr 2025."

Quick Takeaways

  • Atlas Venture Fund XII, L.P. filed SCHEDULE 13D/A for JADE BIOSCIENCES, INC. Common Stock (JBIO).
  • Disclosed ownership: 0.2%.
  • Date of event: 28 Apr 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 30 Apr 2025, 16:29.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Atlas Venture Fund XII, L.P. 0.2% 50,992 0 50,992 /s/ Ommer Chohan By: Atlas Venture Associates XII, L.P., its general partner, By: Atlas Venture Associates XII, LLC, its general partner, By: Ommer Chohan, its CFO 0001812049
Atlas Venture Associates XII, L.P. 0.2% 51,406 0 51,406 /s/ Ommer Chohan By: Atlas Venture Associates XII, LLC, its general partner, By: Ommer Chohan, its CFO 0001845875
Atlas Venture Associates XII, LLC 0.2% 51,406 0 51,406 /s/ Ommer Chohan Ommer Chohan, CFO 0001845871
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .